flurbiprofen has been researched along with Uveitis in 5 studies
Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.
Uveitis: Inflammation of part or all of the uvea, the middle (vascular) tunic of the eye, and commonly involving the other tunics (sclera and cornea, and the retina). (Dorland, 27th ed)
Excerpt | Relevance | Reference |
---|---|---|
" We have tested the efficacy of topically given S(+)-ibuprofen in a rabbit model of uveitis secondary to the intravitreal injection of human recombinant interleukin 1-alpha." | 3.68 | The effects of topical S(+)-ibuprofen on interleukin-1 induced ocular inflammation in a rabbit model. ( Boney, RS; Goldenberg, MM; Rosenbaum, JT; Tilden, ME, 1990) |
"Prednisone was started and prognosis was favorable." | 1.38 | Drug-induced TINU syndrome and genetic characterization. ( Bellinghieri, G; Cavallari, V; Gangemi, S; Rovito, S; Santoro, D; Savica, V; Venuto, L; Vita, G; Vita, R, 2012) |
" No significant difference was found between the ocular bioavailability of FBA-EM F2 and 0." | 1.37 | Novel NSAIDs ophthalmic formulation: flurbiprofen axetil emulsion with low irritancy and improved anti-inflammation effect. ( Dong, Y; Gan, L; Gan, Y; Jiang, M; Shen, J; Zhang, X; Zhu, C; Zhu, J, 2011) |
"The treatment with flurbiprofen and indomethacin administered subcutaneously every 12 hours, commenced on the day of S-antigen injection and was continued until the termination of the experiment (12 days)." | 1.28 | Modulation of immune responses by cyclo-oxygenase inhibitors during intraocular inflammation. ( Bhattacherjee, P; Jaramillo, A; Paterson, CA; Sonnenfeld, G, 1992) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shen, J | 1 |
Gan, L | 1 |
Zhu, C | 1 |
Zhang, X | 1 |
Dong, Y | 1 |
Jiang, M | 1 |
Zhu, J | 1 |
Gan, Y | 1 |
Santoro, D | 1 |
Vita, G | 1 |
Rovito, S | 1 |
Venuto, L | 1 |
Cavallari, V | 1 |
Vita, R | 1 |
Savica, V | 1 |
Bellinghieri, G | 1 |
Gangemi, S | 1 |
Hillman, JS | 1 |
Frank, GJ | 1 |
Kheskani, MB | 1 |
Jaramillo, A | 1 |
Bhattacherjee, P | 1 |
Sonnenfeld, G | 1 |
Paterson, CA | 1 |
Tilden, ME | 1 |
Boney, RS | 1 |
Goldenberg, MM | 1 |
Rosenbaum, JT | 1 |
1 trial available for flurbiprofen and Uveitis
Article | Year |
---|---|
Flurbiprofen and human intraocular inflammation.
Topics: Aqueous Humor; Cataract Extraction; Clinical Trials as Topic; Conjunctivitis; Corneal Diseases; Doub | 1980 |
4 other studies available for flurbiprofen and Uveitis
Article | Year |
---|---|
Novel NSAIDs ophthalmic formulation: flurbiprofen axetil emulsion with low irritancy and improved anti-inflammation effect.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aqueous Humor; Biological Availability; Cell Count | 2011 |
Drug-induced TINU syndrome and genetic characterization.
Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Female; Flurbiprofen; Haplotypes; | 2012 |
Modulation of immune responses by cyclo-oxygenase inhibitors during intraocular inflammation.
Topics: Animals; Antigens; Arrestin; Autoantibodies; Dinoprostone; Disease Models, Animal; Eye Proteins; Fem | 1992 |
The effects of topical S(+)-ibuprofen on interleukin-1 induced ocular inflammation in a rabbit model.
Topics: Administration, Topical; Animals; Aqueous Humor; Capillary Permeability; Cell Count; Disease Models, | 1990 |